Abstract

In Reply .—We are most encouraged to see that our findings 1 have prompted other investigators to research the effects of captopril therapy on cystine excretion in cystinuria. The individual case study performed by Dahlberg and Jones demonstrates a close correlation between urinary cystine determinations as quantitated both by the ion exchange–triketohydrindene hydrate (Ninhydrin) method and the phosphotungstic method that we used. The reason for the discrepancy between their results and those we obtained is unclear. As suggested by these authors, both the excretion of cystine and the effect of a vasoactive drug such as captopril on that excretion is probably multifactorial. Genetic subtypes of cystinuria could account not only for differing renal tubular handling of cystine, dibasic amino acid, and, possibly, captopril, but also for intestinal transport of these substances. 2 Alternatively, their patient, who had such high levels of urinary cystine, may not have received enough captopril to

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.